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Abstract  
 
Context:  Sudden infant death syndrome (SIDS) is a leading cause of postneonatal infant 
mortality. Our prior meta-analyses showed that any breastfeeding is protective against SIDS, 
and that this effect is stronger with exclusive breastfeeding. It is unclear what duration of 
breastfeeding is required to confer a protective effect.  
Objective: Assess the associations between duration of breastfeeding and SIDS.  
Data Sources:  Individual-level data from 8 case-control SIDS studies. 
Study Selection: All case-control SIDS studies with breastfeeding data. 
Data Extraction: Variables for breastfeeding, demographic factors, and other potential 
confounders were identified.  Individual-study and pooled analyses were performed.  
Results: 2267 SIDS cases and 6837 control infants were included. In multivariable pooled 
analysis, breastfeeding for <2 months was not protective (aOR 0.91; 95%CI=0.68-1.22). Any 
breastfeeding ≥2 months was protective, with greater protection seen with increased duration 
(2-4 months: aOR 0.60, 95%CI=0.44-0.82; 4-6 months: aOR 0.40, 95%CI=0.26-0.63; and 6+ 
months: aOR 0.36; 95%CI=0.22-0.61). Although exclusive breastfeeding for <2 months was 
not protective (aOR 0.82; 95%CI=0.59-1.14), longer periods were protective: (2-4 months: 
aOR 0.61, 95%CI=0.42-0.87; and 4-6 months: aOR 0.46, 95%CI=0.29-0.74). In sensitivity 
analyses only minor changes were seen in the odds ratios, suggesting robustness of the 
results.  
Limitations: The variables collected in each study varied slightly, limiting our ability to 
include all studies in the analysis controlling for all confounders. 
Conclusions and Relevance: Breastfeeding duration of at least 2 months was associated with 
a protective effect against SIDS, with an approximate halving of risk. Breastfeeding does not 
need to be exclusive to confer this protection.  
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Introduction 
 
Breastfeeding has been shown in several studies to be associated with a decreased risk of 
Sudden Infant Death Syndrome (SIDS).1-3 In a previous meta-analysis, we have shown that 
breastfeeding is protective against SIDS (adjusted Odds Ratio (aOR)=0.55; 95% CI: 0.44, 
0.69 for any breastfeeding), and that this protective effect is stronger with exclusive 
breastfeeding (OR=0.27; 95% CI: 0.24, 0.31).3 
 
However, it has been difficult to determine what duration of breastfeeding is required to 
confer a protective effect against SIDS. This may partly be because the incidence of 
breastfeeding across countries and different cultures varies and because the different studies 
investigating the association with SIDS use different definitions for any breastfeeding, 
exclusive breastfeeding and the duration of either practice. Meta-analyses of breastfeeding 
duration at the study level are difficult to undertake, and so far the effect size and the duration 
of breastfeeding required to confer this protective effect have not been quantified. 
 
We therefore aimed to use individual-level data from international studies, and with co-
operation of the individual authors, to assess the associations between duration of any 
breastfeeding and exclusive breastfeeding and SIDS. 
 
Methods 
We used the same review protocol as that in our previously reported meta-analysis.3 We 
searched the Ovid Medline database (January 1966 through December 2009) to collect data 
on breastfeeding and its association with SIDS. The search strategy included published 
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articles limited to humans with the Medical Subject Headings terms “sudden infant death” 
and “breast feeding” with key words “sudden infant death syndrome, “SIDS,” “cot death,” 
and“breastfeeding.”Of the 18 studies included in the meta-analysis individual level data were 
provided from 8 large case-control studies of SIDS deaths, which comprise all of the 
published case-control studies with individual-level data about breastfeeding status. In all 
studies, there were strict definitions and protocols for determining SIDS cases. The cause of 
death had to be ascertained by local medical examiners, pediatric or forensic pathologists. No 
studies without individual-level data were included. All data were obtained via direct contact 
with the original investigators for each case-control study. Data were checked by the original 
investigators for completeness and consistency before being released for this analysis. The 
studies include: 
 
The New Zealand Cot Death Study (NZCDS) 
The NZCDS was a national case-control study of all SIDS deaths that took place from 
November 1987 through October 1990. The study successfully recruited and obtained data 
from 393 cases and 1592 controls, who were randomly selected from all births but with an 
age distribution to match the age of cases from 1979-1984.4 Data were obtained by an 
interviewer-administered questionnaire and from hospital obstetric records, which included 
data as to the type of feeding at the time of hospital discharge. Parents were asked whether 
the infant received any breast milk at any stage of life, in the first 4 weeks and the last 2 days. 
In addition, parents of infants who received any breast milk were asked at what stage 
breastfeeding stopped (age in weeks). Coding was available for never started and still 
breastfeeding.  
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The Chicago Infant Mortality Study (CIMS) 
The CIMS studied all SIDS deaths in Chicago, Illinois, US between November 1993 and 
April 1996, and included 260 cases and 260 controls, who were matched by maternal 
ethnicity, age at death and birthweight.5 Data on breastfeeding were collected by a 
standardized interviewer-administered questionnaire. Parents were asked if the child had ever 
been breastfed, if the child was still being breastfed, and how old the child was when 
breastfeeding stopped. In addition, data on other methods of feeding and when they started 
were collected so that duration of exclusive breastfeeding could be calculated.  
 
The German SIDS Study (GeSID) 
The GeSID was carried out in 11 of 18 states in the Federal Republic of Germany between 
November 1998 and October 2001. The study included 333 SIDS cases and 998 controls, 
who were matched by geographic region, age, gender and reference sleep (i.e., time of sleep 
was matched to the time of death for the respective case).6 Data on breastfeeding were 
collected by a standardised, interviewer-administered questionnaire. Questions were asked 
about breastfeeding at 2 weeks of age and each month of age through 12 months (when 
applicable) and whether this breastfeeding was exclusive.  
 
The Scottish Cot Death Trust Study 
The Scottish Cot Death Trust study took place between January 1996 and May 2000. Data 
were collected on 131 SIDS cases and 278 control infants who were matched by age, season, 
and obstetric unit.7 Data on breastfeeding were collected by a standardised, interviewer-
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administered questionnaire. Questions were asked about which types of feeding the infant 
had, and if not breastfed currently whether they had ever breastfed and when they stopped. 
 
European Concerted Action on SIDS (ECAS) 
The ECAS was comprised of case-control studies in 20 regions in Europe between September 
1992 and April 1996.8 Data for the current analyses were restricted to those centres for which 
we had not obtained data from elsewhere (Sweden, Norway, Denmark, Netherlands, Austria, 
Hungary, Ukraine, Spain, Italy, Russia, Slovenia, France, Belgium, Poland and UK 
(Cambridge)). Data were collected for 382 SIDS cases and 1159 controls. Data on 
breastfeeding exclusivity and duration were collected by interviewer-administered 
questionnaires. Questions were asked about how the infant was being fed at the time of death 
or interview. 
 
Irish Study of Infant Death 
The Irish study was part of an ongoing case-control study of infant death in the Republic of 
Ireland that began collecting data in 1994 and continued until 2010.9,10 Controls were 
matched by date of birth and geographical location. The data included in this analysis 
comprise 363 cases and 1163 controls for the period 1994-2003. Data on breastfeeding 
exclusivity and duration were collected during standardized home interviews. 
 
Confidential Enquiry into Stillbirth and Deaths in Infancy (CESDI) 
CESDI was comprised of 5 regions of England between 1993 and 1996.11 Data were 
collected for 325 SIDS cases and 1300 controls, who were matched by age and health visitor. 
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Data were collected for duration of breastfeeding; however, no information on duration of 
exclusiveness of breastfeeding was collected. 
 
South-West England Infant Sleep Study (SWISS) 
The SWISS comprised of 2 regions in the South-West of England between 2003 and 2006.12 
Data were collected for 80 SIDS cases and 87controls. Data were collected for duration of 
breastfeeding; however, no information on duration of exclusiveness of breastfeeding was 
collected. 
 
Definitions of breastfeeding variables 
Duration of any breastfeeding was defined as the length of time that the infant received any 
human milk, either through breastfeeding or expressed breast milk, either exclusively or in 
combination with other foods (including infant formula). We defined the duration of any 
breastfeeding as a continuous variable; we created a categorical variable for duration of any 
breastfeeding (0-2 months, 2-4 months, 4-6 months, and >6 months). 
 
Duration of exclusive breastfeeding was defined as the length of time that the infant received 
only human milk, either through breastfeeding or expressed breast milk.13 We defined the 
duration of exclusive breastfeeding as a continuous variable; we created a categorical variable 
for duration of exclusive breastfeeding (0-2 months, 2-4 months, >4 months). A variable for 
>6 months was not created due to the very small numbers in this group in most of the studies. 
 
Statistical analysis 
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Analysis was performed for each study individually, and then data were combined for a 
pooled analysis. A pooled univariable analysis, using all 8 studies, was conducted, controlling 
for study. A multivariable model was then fitted using 3 of the studies (NZCDS, CIMS and 
GeSID) for which all 19 potential confounders were available (Model 1). These confounders 
had initially been assessed as being available and consistent across these three studies at the 
inception of the study and have been identified as risk or protective factors for SIDS: sleep 
position at last sleep (supine, side, prone), maternal smoking during pregnancy (yes/no), 
bedsharing in the last sleep (infant sleeping with another person on the same surface) 
(yes/no), roomsharing in the last sleep (infant sleeping in the same room as an adult caregiver 
but on a separate surface) (yes/no), use of a dummy/pacifier in the last sleep (yes/no), 
maternal age, prenatal care received (yes/no), marital status (married/not married), parity 
(primiparous/multiparous), maternal education (university graduate or not), socio-economic 
status (SES) (low, middle, high), infant age (<13 weeks, 13-19 weeks, 20-26 weeks,>26 
weeks), infant sex, admission to a special care baby unit (yes/no), season at death, 
birthweight (<2500g, 2500g-2999g, 3000g-3499g,>=3500g), gestational age at birth (28-33 
weeks, 34-37 weeks, 38+ weeks), multiple pregnancy (yes/no) and caesarean section 
(yes/no). Additional models were then fitted to include the other 5 studies at the expense of 
reducing the number of confounders but increasing sample size.  These sequential models did 
not include the following confounders:  caesarean section (CESDI and SWISS included in 
model, Model 2), SES and season (Irish and ECAS included, Model 3) and finally antenatal 
care and maternal education level (Scottish included, Model 4). 
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All analyses were carried out in SAS 9.4 (SAS Institute, Cary, NC, USA). Odds ratios were 
estimated using the proc logistic procedure, with a strata statement for study in pooled 
analyses. Survival curves were produced for duration of any breastfeeding for control groups 
using proc lifetest, with data censored if breastfeeding was still taking place. Statistical 
significance was defined at the 5% level.  
 
This study was approved by the Institutional Review Board at the University of Virginia. 
Further, the individual studies were approved by the institutional ethical review boards/ethics 
committees according to the laws and standards of each country. 
 
Results  
There are 8 SIDS case-control studies with individual-level data; all were included (see 
Figure 1 flow diagram). A total of 2267 SIDS cases and 6837 control infants were included in 
this analysis. There was great variability in rates of any breastfeeding and exclusive 
breastfeeding in the studies (Log Rank=1659.6, p<0.0001).  This is illustrated in Figure 2 
which shows survival curves for any breastfeeding for controls from each of the studies. 
Breastfeeding rates were highest in New Zealand and lowest in the United States, with the 
European countries having intermediate rates. At six months the rate of any breast feeding 
ranged from over 50% in NZ and ECAS to less than 10% in several of the studies. 
 
Any Breastfeeding 
The univariable effects of any breastfeeding stratified by study and the pooled analyses are 
shown in Table 1. The analysis categorizing duration of any breastfeeding showed that those 
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who breastfed for less than 2 months incurred a protective effect (OR=0.61; 95% CI: 0.54, 
0.69), and those breastfeeding 2-4 months had a greater protective effect (OR=0.26; 95% CI: 
0.22, 0.30). Breastfeeding duration beyond 4 months provided further small increases in 
protection (4-6 months: OR=0.18; 95% CI: 0.14, 0.23; 6+ months: OR=0.13; 95% CI: 0.10, 
0.18). The multivariable pooled analysis for the 3 studies with all 19 confounders controlled 
for found ongoing protective effects of any breastfeeding beyond two months (2-4 months: 
aOR=0.60; 95% CI: 0.44, 0.82; 4-6 months:  aOR= 0.40; 95% CI: 0.26, 0.63, and 6+ months: 
aOR=0.36; 95% CI: 0.22, 0.61) (Table 2). However, breastfeeding for 0-2 months did not 
have a statistically significant protective effect (aOR=0.91; 95% CI: 0.68, 1.21). The removal 
of caesarean section from the model had little effect on the odds ratios; however the removal 
of SES and season in model 3 saw the protective effects of any breastfeeding become 
stronger. The further removal of maternal education and antenatal care in model 4 had little 
additional influence on the aOR, but this result reached statistical significance (aOR 0.83; 
95% CI: 0.70, 0.99). 
 
Exclusive breastfeeding 
The stratified and pooled analysis for the univariable effects of exclusive breastfeeding is 
shown in Table 1. The analysis categorizing duration of exclusive breastfeeding showed that 
those who exclusively breastfed for less than 2 months incurred a protective effect (OR=0.61; 
95% CI: 0.53, 0.71), and those breastfeeding 2-4 months had a greater protective effect 
(OR=0.25; 95% CI: 0.20, 0.30). Exclusive breastfeeding for >4 months provided a further 
increase in protection (OR=0.16; 95% CI: 0.12, 0.21). As in the multivariable analysis for 
any breastfeeding which controlled for all potential confounders,  those who breastfed 
  
 
 
 
 
13 
exclusively for less than 2 months did not see any statistically significant protective effect 
(aOR=0.82; 95% CI: 0.59, 1.14), but those who breastfed for longer than 2 months incurred a 
protective effect (aOR=0.61; 95% CI: 0.42, 0.97) for 2-4 months, with increasing protection 
with longer duration (aOR=0.46;95% CI: 0.29, 0.74) for those exclusively breastfeeding >4 
months. Similarly, the removal of SES and season from the model made the effect sizes 
slightly stronger. 
 
Discussion 
We conducted a pooled analysis of individual-level data from 8 major international case-
control studies with 2259 cases and 6894 controls to assess the association between duration 
of any breastfeeding and exclusive breastfeeding and SIDS. Although there was some 
protection seen with breastfeeding for less than 2 months in univariable analysis, after 
controlling for potential confounders, we found no statistically significant protection against 
SIDS until infants had breastfed for at least 2 months. After 2 months, the adjusted odds ratio 
for any breastfeeding was 0.60 (95% CI=0.44, 0.82), while the adjusted odds ratio for 
exclusive breastfeeding was 0.61 (95% CI=0.42, 0.87). It is thus important that public health 
messages about SIDS risk reduction emphasize that breastfeeding, if it to be protective, must 
continue for at least 2 months. This analysis does not demonstrate any advantage to exclusive 
breastfeeding over partial breastfeeding, which may be reassuring to some parents who 
cannot or do not wish to exclusively breastfeed their infant. 
 
It is yet unclear why breastfeeding offers protective effects against SIDS. Physiologic, 
neuropathologic, and genetic studies point to dysfunctional arousal responses as a mechanism 
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that creates an intrinsic vulnerability in the infant, which predisposes the infant to SIDS,14 
and breastfed infants are more easily aroused from sleep than are formula-fed infants.15,16 
There are also differences in maternal responses to an infant’s behavioral cues, depending on 
feeding mode, which may impact infant sleep and arousal patterns.17,18 Additionally, 
breastfeeding provides immune benefits and is associated with a lower incidence of viral 
infections, which are associated with an increased risk of SIDS.19-21 Breast milk contains 
substances that may contribute to myelin development; Kinney and co-authors found that 
infants who died from SIDS had delayed myelination of the brain compared with control 
infants.22  Breast milk also contains higher levels of docosahexaenoic acid (DHA) compared 
with formula, which is an important structural and functional component of the developing 
infant brain. One study of autopsied brains of SIDS infants found that the frontal lobes of the 
breastfed infants had higher levels of DHA, compared with those of formula-fed infants, it is 
unknown if this difference exists in non SIDS infants.23  Finally, it is possible that 
breastfeeding is a distal marker of or proxy for complex protective infant care practices that 
have not yet been measured, though we would expect that such a marker would be related to 
socio-demographic variables that have been controlled for in these analyses. 
 
It is unclear why exclusive breastfeeding did not offer any additional protection against SIDS 
than any, i.e., partial breastfeeding. This is a common challenge in studies that have looked at 
the differential effects of exclusive and partial breastfeeding, because of differing definitions 
of breastfeeding and confounding factors.1,24 The analysis accounted for as many 
demographic and risk factor variables as were possible, but we acknowledge that the effects 
reported could be due to residual confounding, though this would be unlikely. It was notable 
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that inclusion of studies that did not have data on SES increased the protective effect further 
from the null, thus seemingly showing the importance of SES as a confounder in relation to 
breastfeeding. Given that lower SES is a risk factor for SIDS, it is possible that the protective 
effect of SES may in part be explained by increased breastfeeding rates. However, Model 3, 
which did not have data on SES also did not have data on season. While SES is associated 
with breastfeeding it is unlikely there is a relationship between season and breastfeeding, thus 
we believe that these changes in estimates are likely to be associated with SES. 
  
Other limitations of this study are related to issues with combining data in the individual 
case-control studies. These case-control studies were all conducted in a rigorous manner and 
are the basis for most of the current infant safe sleep guidelines in developed countries.25-27 
However, as noted above, the variables collected in the course of each study varied slightly, 
limiting our ability to include all studies in the analysis controlling for all confounders. 
However, the results of the univariable analysis using just the 3 countries included in the 
completely controlled multivariable model (model 1) did not differ greatly from the 
univariable analysis with all 8 studies, so it is unlikely that including the additional studies 
would have changed the results of the analysis in any meaningful way. 
 
Given these findings, there should be ongoing concerted efforts to increase rates of 
breastfeeding initiation and maintenance. Among the control infants in five of the eight 
countries in this analysis, the proportion of infants who were breastfeeding at 2 months of age 
was <50%, and <30% at 4 months of age. In more recent years, national breastfeeding rates 
have increased; 2007 OECD data show that the proportions of infants who were ever 
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breastfed in the countries included in our study were 42% in Ireland, 75% in the US, 77% in 
the UK, 85% in New Zealand, and 89% in the European Union.28 The World Health 
Organization’s 2025 targets for breastfeeding are to have >50% of infants exclusively 
breastfeeding for at least 6 months.13Further increases in breastfeeding rates will result in 
lower infant mortality as a whole,24,29 and decreases in SIDS rates,3 specifically. 
 
In conclusion, breastfeeding duration of a minimum of 2 months appears to be necessary to        
confer a significant protective effect against SIDS, with an almost halving of the risk. The 
protective benefits of breastfeeding increase as the duration increases. However, exclusive 
breastfeeding does not confer additional benefits over partial breastfeeding with regards to 
SIDS risk reduction. Therefore, mothers should be encouraged to breastfeed for at least 2 
months (and preferably longer). Even if mothers are unable to exclusively breastfeed, they 
can feel reassured that any breastfeeding provides protection against SIDS to their infants.  
Further study is still needed to better understand the mechanisms by which breastfeeding 
offers protection.    
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Figure legends 
Figure 1: PRISMA flow diagram for pooled analyses using individual-level data 
Figure 2: Kaplan Meier survival curves for proportion of controls still Breastfeeding, 
stratified by study 
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Figure 2 
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Table 1: Stratified and pooled univariable odds ratio (95% CI) of SIDS for duration of any and 
exclusive breastfeeding  
 
Any breastfeeding (months) 
 New Zealand Germany USA Scottish Pooled 
Never 1.00 1.00 1.00 1.00  
>0 to 2 0.79 (0.55, 1.13) 0.70 (0.48, 1.02) 0.43 (0.28, 0.65) 0.65 (0.41, 1.05) 
>2 to 4 0.49 (0.33, 0.71) 0.18 (0.13, 0.25) 0.07 (0.03, 0.21) 0.16 (0.06, 0.47) 
>4 to 6 0.32 (0.19, 0.53) 0.10 (0.06, 0.16) 0.06 (0.01, 0.51) 0.20 (0.04,0.90) 
>6 months 0.19 (0.09, 0.37) 0.15 (0.10, 0.25) undefined undefined 
     
 ECAS CESDI SWISS Irish 
Never 1.00 1.00 1.00 1.00 1.00 
>0 to 2 0.56 (0.36, 0.88) 0.61 (0.46, 0.81) 0.79 (0.37, 1.67) 0.68 (0.51, 0.92) 0.61 (0.54, 0.69) 
>2 to 4 0.21 (0.13, 0.33) 0.42 (0.28, 0.64) 0.42 (0.16, 1.12) 0.16 (0.09, 0.29) 0.26 (0.22, 0.30) 
>4 to 6 0.20 (0.12, 0.33) 0.39 (0.20, 0.78) 0.15 (0.02, 1.40) 0.04 (0.01, 0.26) 0.18 (0.14, 0.23) 
>6 months 0.07 (0.03, 0.14) 0.25 (0.09, 0.70) 0.11 (0.01, 0.95) 0.22 (0.07, 0.72) 0.13 (0.10. 0.18) 
      
Exclusive breastfeeding 
 New Zealand Germany USA Scottish Pooled 
Never 1.00 1.00 1.00 1.00  
>0 to 2 0.88 (0.58, 1.34) 0.40 (0.28, 0.56) 0.46 (0.28, 0.76) 0.63 (0.39, 1.03) 
>2 to 4 0.41 (0.27,0.64) 0.22 (0.15, 0.33) 0.18 (0.02, 1.51) 0.21 (0.06, 0.73) 
  4-6 
months 
0.32 (0.10, 1.03) 0.13 (0.09, 0.20) undefined undefined 
     
 ECAS CESDI SWISS Irish 
Never 1.00 Not available Not available 1.00 1.00 
>0 to 2 0.98 (0.73, 1.32) 0.40 (0.28, 0.58) 0.61 (0.53, 0.71) 
>2 to 4 0.29 (0.21, 0.41) 0.12 (0.05, 0.30) 0.25 (0.20, 0.30) 
4-6 months 0.19 (0.12, 0.31) 0.48 (0.16, 1.41) 0.16 (0.12, 0.21) 
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Table 2: Stratified and pooled multivariable odds ratios (95% CI) of SIDS for duration of any 
breastfeeding  
 
 New Zealand Germany USA Scottish 
Never 1.00 1.00 1.00 1.00 
>0 to 2 0.86 (0.53, 1.40) 0.89 (0.49, 1.63) 0.69 (0.36, 1.31) 0.69 (0.31, 1.52) 
>2 to 4 0.67 (0.40, 1.11) 0.51 (0.29, 0.88) 0.16 (0.04, 0.71) 0.38 (0.09, 1.54) 
>4 to 6 0.39 (0.19, 0.80) 0.37 (0.18, 0.74) 0.16 (0.01, 1.72) 0.20 (0.03, 1.57) 
>6 months 0.44 (0.17,  1.13) 0.30 (0.15, 0.63) undefined undefined 
     
 ECAS CESDI SWISS Irish 
Never 1.00 1.00 1.00 1.00 
>0 to 2 0.79 (0.25, 2.51) 0.96 (0.65, 1.40) 0.12 (0.01, 2.18) 1.13 (0.59, 2.17) 
>2 to 4 0.82 (0.25, 2.73) 0.78 (0.45, 1.34) 0.02 (<0.001, 0.93) 0.19 (0.07, 0.51) 
>4 to 6 0.94 (0.23, 3.94) 0.64 (0.24, 1.75) <0.001 (<0.001, 3.50) 0.08 (0.01, 0.86) 
>6 months 0.06 (0.00, 0.94) 0.26 (0.05, 1.25) 0.001 (<0.001, 1.71) 0.45 (0.06, 3.09) 
     
 Pooled Model 1a Pooled Model 2b Pooled Model 3c Pooled Model 4d 
 n=3386 n=5008 n=6121 n=7842 
Never 1.00 1.00 1.00 1.00 
>0 to 2 0.91 (0.68, 1.21) 0.90 (0.72,1.12) 0.83 (0.69, 1.01) 0.83 (0.70, 0.99) 
>2 to 4 0.60 (0.44, 0.82) 0.62 (0.48, 0.80) 0.52 (0.41, 0.65) 0.46 (0.37, 0.56) 
>4 to 6 0.40 (0.26, 0.63) 0.42 (0.29, 0.61) 0.38 (0.27, 0.54) 0.40 (0.30, 0.53) 
>6 months 0.36 (0.22, 0.61) 0.34 (0.22, 0.54) 0.33 (0.21, 0.50) 0.25 (0.17, 0.37) 
 
a Model 1 controlled for sleep position at last sleep, maternal smoking during pregnancy, bedsharing in the last 
sleep (infant sleeping with another person on the same surface), roomsharing in the last sleep (infant sleeping in 
the same room as an adult caregiver but on a separate surface) , dummy/pacifier in the last sleep. maternal age, 
prenatal care, marital status, parity, maternal education, socio-economic status, infant age, infant sex, admission 
to a special care baby unit, season at death, birthweight, gestational age, multiple pregnancy and caesarean 
section. 
b Model 2 controlled for variables in model 1 except for caesarean Section to include CESDI and SWISS 
studies. 
c Model 3 controlled for variables in model 2 except season and socio-economic status to include ECAS and 
Irish studies. 
d Model 4controlled for variables in model 3 except for antenatal care and maternal education to include Scottish 
study. 
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Table 3: Stratified and pooled multivariable odds ratios (95% CI) of SIDS for duration of 
exclusive breastfeeding  
 
 New Zealand Germany USA Scottish 
Never 1.00 1.00 1.00 1.00 
>0 to 2 1.02 (0.56, 1.84) 0.70 (0.41, 1.19) 0.81 (0.39, 1.69) 0.61 (0.26, 1.44) 
>2 to 4 0.47 (0.27, 0.83) 0.51 (0.29, 0.90) 0.61 (0.04, 8.83) 0.63 (0.12, 3.23) 
4-6 months 0.56 (0.15, 2.07) 0.31 (0.17, 0.58) undefined Undefined 
     
 ECAS CESDI SWISS Irish 
Never 1.00 Not available Not available 1.00 
>0 to 2 1.27 (0.46, 3.48) 0.68 (0.33, 1.42) 
>2 to 4 0.48 (0.15, 1.53) 0.09 (0.02, 0.53) 
4-6 months 0.60 (0.14, 2.54) 3.14 (0.56, 17.55) 
     
 Pooled Model 1a Pooled Model 2b Pooled Model 3c Pooled Model 4d 
 n=3397  n=4319 n=6006 
Never 1.00  1.00 1.00 
>0 to 2 0.82 (0.59, 1.14)  0.75 (0.58, 0.98) 0.82 (0.67, 1.01) 
>2 to 4 0.61 (0.42, 0.87)  0.44 (0.32, 0.60) 0.40 (0.31, 0.51) 
4-6 months 0.46 (0.29, 0.74)  0.47 (0.31, 0.71) 0.37 (0.26, 0.52) 
 
a Model 1 controlled for sleep position at last sleep, maternal smoking during pregnancy, bedsharing in the last 
sleep (infant sleeping with another person on the same surface), roomsharing in the last sleep (infant sleeping in 
the same room as an adult caregiver but on a separate surface) , dummy/pacifier in the last sleep. maternal age, 
prenatal care, marital status, parity, maternal education, socio-economic status, infant age, infant sex, admission 
to a special care baby unit, season at death, birthweight, gestational age, multiple pregnancy and caesarean 
section. 
b Model 2 excluded CESDI and SWISS studies, which had no data on exclusive breastfeeding. Not available as 
these two studies had no data on exclusive breastfeeding 
c Model 3 controlled for variables in model 2 except for season and socio-economic status to include ECAS and 
Irish studies. 
d Model 4controlled for variables in model 3 except for antenatal care and maternal education to include Scottish 
study. 
 
